<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3046</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2020.12212</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>A Current Review on the Pathogenesis and Treatments of Vitiligo&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ghosh</surname><given-names>Debosree</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ghosh</surname><given-names>Suvendu</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>12</day><month>11</month><year>2020</year></pub-date><volume>1)</volume><issue/><fpage>19</fpage><lpage>24</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Vitiligo is recognized as an acquired autoimmune depigmentation disorder. Normally, the disease occurs before forty years of age but it has been reported to be effecting people irrespective of age and sex. Body produces antibodies against melanocytes and destroys them. As a result, white patches appear in the body. Vitiligo may be segmental or non-segmental. Objectives of this review article is to understand the underlying mechanism of occurrence of vitiligo, brief an updated information about the available treatments and the possible precautionary measures against vitiligo. All available literature about vitiligo and it__ampersandsignrsquo;s treatment procedures were studied and thus all available information has been reviewed and briefed in this article to represent a compact scenario of the pathogenesis and treatments of vitiligo to make the understanding of the disease clear. Vitiligo has significant social and psychological impacts and physiological adverse effects like hypopigmentation or depigmentation in the patient. The social and psychological impact that the disease brings with it is severe in most cases. Vitiligo is not completely curable but treatments include topical corticosteroids, immune-modulators, and UV therapy which causes repigmentation of white patches, micro pigmentation etc.&#13;
</p></abstract><kwd-group><kwd> Autoimmune</kwd><kwd> Depigmentation</kwd><kwd> Hypopigmentation</kwd><kwd> Melanocytes</kwd><kwd> Vitiligo</kwd></kwd-group></article-meta></front></article>
